熱門詞： 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
熱門詞： 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
Lilly Ventures Lilly Ventures,
禮來公司的第一支投資基金—禮來風(fēng)險(xiǎn)基金（Lilly Ventures, ）設(shè)立于2001年，專注于北美和歐洲地區(qū)的投資。
禮來亞洲基金（Lilly Asia Ventures）設(shè)立于2008年，專注于亞洲尤其是中國(guó)地區(qū)的投資.我們也是目前中國(guó)唯一的一支由跨國(guó)制藥公司設(shè)立的投資基金。通過禮來公司這根紐帶，我們?yōu)楸煌顿Y公司帶來巨大的戰(zhàn)略資源并提供出色的增值服務(wù)。
Lilly Ventures has its roots in the scientific tradition of Eli Lilly and Company. Our investment philosophy drives us to seek great companies with compelling life science innovations. We partner actively with the management teams of our portfolio companies to realize the potential of their technologies. Accordingly, we provide both financial and intellectual resources to accelerate the management teams’ path to success. Lilly Ventures currently has $200 million under management with a focus on the North American and European regions.
Investment Focus
Biotechnology: targeting investments in biotechnology companies that leverage proprietary drug discovery or development technologies to build a multi-product pipeline.
Medical Technology: targeting investments in companies focusing on the convergence of devices with pharmaceuticals or diagnostics.
Value Added Resources
ACCESS TO INDUSTRY KNOWLEDGE AND CONTACTS
Through our relationship with Eli Lilly and Company, Lilly Ventures provides our portfolio companies with access to the collective knowledge and contact base generated by Lilly's world-class scientists, experienced clinical investigators and respected sales and marketing professionals
PRODUCT INSIGHTS
Our relationship with Eli Lilly and Company greatly enhances our ability to evaluate new technologies and therapies from a customer or prospective partner perspective.
STRATEGIC RELATIONSHIPS
Our collaborations with industry experts, the venture capital industry and investment banks give us a global network of contacts to assist portfolio companies with various aspects of growing their business.
知識(shí)產(chǎn)權(quán)侵權(quán)投訴：不生產(chǎn)任何產(chǎn)品所有產(chǎn)品均來自產(chǎn)品的生產(chǎn)廠商、代理商、經(jīng)銷商，如有侵權(quán)請(qǐng)聯(lián)系：400-006-7520 ，我們會(huì)在第一時(shí)間處理
本網(wǎng)站所有產(chǎn)品與藥品無關(guān)
滬公網(wǎng)安備31011502016460號(hào)
